At JRG Partners we sit on the other side of these searches every day, so this reflects what we actually see working for candidates. Pharmaceutical sales leaders who advance beyond regional and national sales roles are usually the ones who deliberately built capability outside selling, because the ceiling for pure sales excellence is lower than most people expect. The step from leading a sales organisation to general commercial leadership requires market access, marketing, and analytical fluency that field careers do not automatically develop.
Key Takeaways
- Sales excellence alone has a lower ceiling than most expect.
- Market access fluency is the most valuable adjacent capability.
- Marketing and analytics experience broadens your candidacy.
- Launch experience is disproportionately valuable.
- Seek cross-functional exposure before you need it.
Where the Sales Track Plateaus
Progression through territory, district, region, and national sales leadership rewards a consistent set of capabilities: driving performance through people, managing sales operations, and executing commercial plans. But the roles above, commercial general management, chief commercial officer, general manager, require deciding what the plan should be, which draws on market access, marketing, pricing, and analytics rather than execution excellence. Sales leaders who have not built these capabilities are frequently regarded as executors rather than strategists, and the plateau is real even for people with outstanding performance records.
Market Access Is the Highest-Value Addition
Of the adjacent capabilities, market access is usually the most valuable for a sales leader to build, because access increasingly determines commercial outcomes and because relatively few sales leaders understand it deeply. Learning how coverage decisions are made, what payers weigh, how health economic arguments are constructed, and how pricing decisions interact with access transforms how you are perceived in commercial leadership discussions. Seek involvement in access strategy, spend time with the function, and take opportunities to contribute to payer-facing work.
Marketing, Analytics, and Launch Experience
Beyond access, brand marketing experience, comfort with commercial analytics and forecasting, and participation in a launch all materially strengthen a sales leader’s candidacy for broader roles. Launches in particular are disproportionately valuable, because they require integrating access, medical, marketing, and field execution under time pressure, which is precisely the integrative work general commercial leadership involves. Volunteering for launch roles, even in a supporting capacity, builds a credential that pure in-line sales leadership does not.
Build Before You Need It
The difficulty is that these capabilities are hardest to acquire when you most need them, since a sales leader applying for a commercial general management role cannot retrospectively acquire access or marketing experience. The work must be done years earlier, while you are performing well in sales and have the standing to request broader involvement. Sales leaders who wait until they feel the plateau typically find the transition considerably harder, because the credentials that would open it take time to build.
What This Looks Like in Practice
A pharmaceutical sales leader deliberately builds market access understanding through involvement in access strategy and payer-facing work, seeks brand marketing and commercial analytics exposure, volunteers for launch roles that require cross-functional integration, and does this while performing strongly in sales rather than after hitting a ceiling.
The Mistake Candidates Keep Making
The most common mistake is assuming that continued strong sales performance is the route to broader commercial leadership, and deepening within the sales track. Outstanding field results establish you as an excellent sales leader, which is precisely the categorisation that limits candidacy for roles requiring strategic rather than execution capability. Performance is mistaken for progression.
Capabilities That Open Broader Commercial Roles
| Capability | Why It Matters |
|---|---|
| Market access fluency | Increasingly determines commercial outcomes |
| Brand marketing experience | Shifts perception from executor to strategist |
| Commercial analytics and forecasting | Required for planning roles |
| Launch participation | Demonstrates cross-functional integration |
| Pricing exposure | Central to commercial strategy |
The Bottom Line
Pharmaceutical sales leaders reach a genuine ceiling on execution excellence alone, so build market access fluency first, add marketing, analytics, and launch experience, and do this while performing strongly rather than after the plateau becomes visible, since the credentials take years to establish. Be deliberate about this, and you will be choosing between offers rather than hoping for one.
Related Reading
For more, see How to Move from Clinical Research to Executive Leadership, Resume Strategies for Pharma Regulatory Affairs Professionals, What Makes a Great VP of Market Access in Pharma.
Frequently Asked Questions
- Q: Why do pharmaceutical sales careers plateau?
- A: Because roles above national sales leadership require deciding commercial strategy rather than executing it, drawing on access, marketing, pricing, and analytics that field careers do not develop.
- Q: Which adjacent capability is most valuable?
- A: Market access, because it increasingly determines commercial outcomes and relatively few sales leaders understand it deeply enough to contribute in strategy discussions.
- Q: Why is launch experience valuable?
- A: Because launches require integrating access, medical, marketing, and field execution under time pressure, which is the integrative work general commercial leadership involves.
- Q: When should I build these capabilities?
- A: While performing strongly in sales, since you have the standing to request broader involvement then and the credentials take years to establish.
- Q: What is the common career mistake?
- A: Assuming continued strong sales performance leads to broader roles, which instead confirms the categorisation as an excellent executor rather than a commercial strategist.
![](https://www.jrgpartners.com/wp-content/uploads/2025/12/tanya-gallardo.jpeg")
Tanya Gallardo
Managing Director, Executive Search & AI Talent Strategy
Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.
With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.
Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.
